<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01875757</url>
  </required_header>
  <id_info>
    <org_study_id>2012-001152-19</org_study_id>
    <secondary_id>2012-001152-19</secondary_id>
    <nct_id>NCT01875757</nct_id>
  </id_info>
  <brief_title>Effect of Supplementation With Vitamin D on the Acute Bronchitis Prevention During the First Year of Life</brief_title>
  <acronym>VitDBR2012</acronym>
  <official_title>Effect of Supplementation With Vitamin D on the Acute Bronchitis Prevention During the First Year of Life</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Universitari Vall d'Hebron Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital Universitari Vall d'Hebron Research Institute</source>
  <brief_summary>
    <textblock>
      A phase III multicenter randomized double blind clinical trial will be conducted. After
      obtaining written consent the infant will be randomized, during the first two weeks of life,
      to a study group to receive either 400 IU or 1,000 IU / day of vitamin D to the year of age.

      Baseline and all follow up visits (2, 6, and 12 months of life) will include anthropometric
      measurements and a questionnaire about health issues. A blood sample will be obtained at
      baseline for analysis of 25OH vitamin D, and at 6 and 12 months for analysis of 25 OH vitamin
      D, and calcium.

      Healthy term born infants of appropriate size for gestational age will be included. We will
      need to include 359 children in each group.

      The primary objective of the study is to decrease the proportion of infants with acute
      bronchitis during the first year of life by supplementation of 1,000 IU/day vitamin D.
      Secondary otcomes are: To check that the administration of 1,000 IU/day vitamin D decreases
      the proportion of infants with upper respiratory tract infections, the proportion of children
      under one year of age hospitalized for acute bronchiolitis, and the demand on the healthcare
      system due to respiratory infections and absences from work for parents and achieves a higher
      proportion of children with adequate blood levels 25 OH vitamin D.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2013</start_date>
  <completion_date type="Actual">December 2016</completion_date>
  <primary_completion_date type="Actual">December 2016</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of children with acute bronchitis</measure>
    <time_frame>1 year</time_frame>
    <description>Check that the administration of a vitamin D dose of 1,000 U / day decreases the percentage of children with acute bronchitis during the first year of life</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of episodes of upper respiratory infections reported by parents in the first year of life</measure>
    <time_frame>1 year</time_frame>
    <description>Check that the supplementation of vitamin D of 1,000 units / day decreases the number of upper respiratory infections</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Percentage of children with recurrent bronchitis</measure>
    <time_frame>1 year</time_frame>
    <description>Check that the supplementation of vitamin D of 1,000 units / day decreases the number of recurrent bronchitis</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">200</enrollment>
  <condition>Acute Bronchitis</condition>
  <condition>Upper Respiratory Tract Infection</condition>
  <condition>Acute Bronchiolitis</condition>
  <arm_group>
    <arm_group_label>Vitamin D3 1000 IU/day</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Infants will be supplemented with vitamin D and/or placebo to receive a total amount of vitamin D3 of 1.000 IU/day during the first year of life, taking into account the vitamin D received with artificial milk</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Vitamin D3 400 IU/day</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Infants will be supplemented with vitamin D and/or placebo to receive a total amount of vitamin D3 of 400 IU/day during the first year of life, taking into account the vitamin D received with artificial milk</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Vitamin D3</intervention_name>
    <arm_group_label>Vitamin D3 1000 IU/day</arm_group_label>
    <arm_group_label>Vitamin D3 400 IU/day</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <arm_group_label>Vitamin D3 1000 IU/day</arm_group_label>
    <arm_group_label>Vitamin D3 400 IU/day</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy term born infants of appropriate size for gestational age

          -  Parents provide informed consent to participate

        Exclusion Criteria:

          -  Infants with small size for gestational age

          -  Infants with gestational age &lt; 37 weeks

          -  Infants with congenital anomalies

          -  Infants with chronic gastrointestinal tract, liver, kidney, heart, or neurological
             diseases

          -  Infants with disorders of vitamin D or calcium metabolism or others inborn errors of
             metabolism
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>19 Days</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Antonio Moreno, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Hospital Universitari Vall d'hebron Barcelona, Spain</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital Universitary Vall d'Hebron</name>
      <address>
        <city>Barcelona</city>
        <zip>08035</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <reference>
    <citation>Camargo CA Jr, Ingham T, Wickens K, Thadhani R, Silvers KM, Epton MJ, Town GI, Pattemore PK, Espinola JA, Crane J; New Zealand Asthma and Allergy Cohort Study Group. Cord-blood 25-hydroxyvitamin D levels and risk of respiratory infection, wheezing, and asthma. Pediatrics. 2011 Jan;127(1):e180-7. doi: 10.1542/peds.2010-0442. Epub 2010 Dec 27.</citation>
    <PMID>21187313</PMID>
  </reference>
  <reference>
    <citation>Belderbos ME, Houben ML, Wilbrink B, Lentjes E, Bloemen EM, Kimpen JL, Rovers M, Bont L. Cord blood vitamin D deficiency is associated with respiratory syncytial virus bronchiolitis. Pediatrics. 2011 Jun;127(6):e1513-20. doi: 10.1542/peds.2010-3054. Epub 2011 May 9.</citation>
    <PMID>21555499</PMID>
  </reference>
  <reference>
    <citation>Karatekin G, Kaya A, Salihoğlu O, Balci H, Nuhoğlu A. Association of subclinical vitamin D deficiency in newborns with acute lower respiratory infection and their mothers. Eur J Clin Nutr. 2009 Apr;63(4):473-7. Epub 2007 Nov 21.</citation>
    <PMID>18030309</PMID>
  </reference>
  <reference>
    <citation>Urashima M, Segawa T, Okazaki M, Kurihara M, Wada Y, Ida H. Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren. Am J Clin Nutr. 2010 May;91(5):1255-60. doi: 10.3945/ajcn.2009.29094. Epub 2010 Mar 10.</citation>
    <PMID>20219962</PMID>
  </reference>
  <reference>
    <citation>Devereux G, Litonjua AA, Turner SW, Craig LC, McNeill G, Martindale S, Helms PJ, Seaton A, Weiss ST. Maternal vitamin D intake during pregnancy and early childhood wheezing. Am J Clin Nutr. 2007 Mar;85(3):853-9.</citation>
    <PMID>17344509</PMID>
  </reference>
  <reference>
    <citation>Camargo CA Jr, Rifas-Shiman SL, Litonjua AA, Rich-Edwards JW, Weiss ST, Gold DR, Kleinman K, Gillman MW. Maternal intake of vitamin D during pregnancy and risk of recurrent wheeze in children at 3 y of age. Am J Clin Nutr. 2007 Mar;85(3):788-95.</citation>
    <PMID>17344501</PMID>
  </reference>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 10, 2013</study_first_submitted>
  <study_first_submitted_qc>June 10, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 12, 2013</study_first_posted>
  <last_update_submitted>March 21, 2017</last_update_submitted>
  <last_update_submitted_qc>March 21, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 22, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Vitamin D</keyword>
  <keyword>Acute bronchitis</keyword>
  <keyword>Upper respiratory tract infection</keyword>
  <keyword>Recurrent bronchitis</keyword>
  <keyword>Acute bronchiolitis</keyword>
  <keyword>Infants</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bronchiolitis</mesh_term>
    <mesh_term>Respiratory Tract Infections</mesh_term>
    <mesh_term>Bronchitis</mesh_term>
    <mesh_term>Acute Disease</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
    <mesh_term>Cholecalciferol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

